Dose Finding Study With CYT003-QbG10 in Patients With House Dust Mite Allergy

NCT00800332 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinoconjunctivitis
Allergies

Interventions

DRUG: CYT003-QbG10
DRUG: Placebo

Sponsor

Cytos Biotechnology AG